Viewing data from:

DEXTROMETHORPHAN POLISTIREX

ANDA

DEXTROMETHORPHAN POLISTIREX | A091135 | TRIS PHARMA INC

1 strength0 unique patents0 unique exclusivities

API Supply Chain3 active DMFs1 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

SOLARA ACTIVE PHARMA SCIENCES LTDDEXTROMETHORPHAN POLISTIREX

DMF 292162015

APITORIA PHARMA PRIVATE LTDDEXTROMETHORPHAN POLISTIREX

DMF 379102022

DASAMI LAB PRIVATE LTDDEXTROMETHORPHAN POLISTIREX

DMF 412862025

CAMBREX CHARLES CITY INCInactiveDEXTROMETHORPHAN POLISTIREX

DMF 223292008

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
May 30, 2012	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 30MG HYDROBROMIDE/5ML

0 patents0 exclusivities▴

SUSPENSION, EXTENDED RELEASE;ORAL | Approved: May 25, 2012

No patent or exclusivity listings for this strength.